Citation
85 FR 49387
Multiple canonical documents share this first-page citation.
- National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Thursday, August 13, 2020 85 FR 49387
- Prospective Grant of an Exclusive Start-Up Patent License for Evaluation: Immunotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma Thursday, August 13, 2020 85 FR 49387